Previous 10 | Next 10 |
home / stock / pbla / pbla articles
Panbela Therapeutics Inc (NASDAQ: PBLA) shares are trading higher by 62% to $1.64 during Tuesday's session on upward momentum. The move co...
U.S. stocks traded higher this morning, with the Dow Jones index gaining around more than 50 points on Tuesday. Following the market opening Tuesda...
Shares of Motus GI Holdings, Inc. (NASDAQ: MOTS) shares fell sharply in pre-market trading after the company priced its $5 million public offerin...
Understanding Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indi...
Shares of Hawaiian Airlines (NASDAQ: HA) shares rose sharply in pre-market trading after Alaska Air Group, Inc. (NYSE: ALK) announced plans to ac...
Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday. GAN Limited (NASDAQ: GAN) sh...
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This ind...
Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740. Seres Therapeutics, Inc. (NASDAQ: MCRB) climbed 45.9% to $1.20. Seres Ther...
Panbela Therapeutics Inc (NASDAQ: PBLA) shares are trading lower by 26% to $0.70 Friday morning. The stock is moving sharply lower after the c...
News, Short Squeeze, Breakout and More Instantly...
Panbela Therapeutics Inc Com Company Name:
PBLA Stock Symbol:
NASDAQ Market:
Panbela Therapeutics Inc Com Website:
DSMB Recommends Continuation without Modification for Third Time Safety Review Included 395 Patients Interim Survival Analysis Still Expected Early 2025 given Lower-Than-Expected Event Rate Low Event Rate Suggests Potential for Prolonged Survival Rapid Enrollment P...
MINNEAPOLIS, June 10, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc . (OTCQB: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announces an oral presentation at the Digestive Disease Week (DDW) conference,...
MINNEAPOLIS, May 15, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the q...